BLCO
Bausch + Lomb Corp (BLCO)
Healthcare • NYSE • $16.18+1.70%
- Symbol
- BLCO
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $16.18
- Daily Change
- +1.70%
- Market Cap
- $5.77B
- Trailing P/E
- N/A
- Forward P/E
- 15.22
- 52W High
- $18.92
- 52W Low
- $10.99
- Analyst Target
- $18.04
- Dividend Yield
- N/A
- Beta
- 0.59
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers p…
Company websiteResearch BLCO on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.